163 related articles for article (PubMed ID: 38308939)
1. Calcitonin gene-related peptide (CGRP) levels in peripheral blood in patients with idiopathic intracranial hypertension and migraine.
Ak AK; Gemici YI; Batum M; Karakaş B; Özmen EY; Gökçay F; Çelebisoy N
Clin Neurol Neurosurg; 2024 Feb; 237():108136. PubMed ID: 38308939
[TBL] [Abstract][Full Text] [Related]
2. Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study.
Krajnc N; Frank F; Macher S; Michl M; Müller N; Maier S; Zaic S; Wöber C; Pemp B; Broessner G; Bsteh G
J Headache Pain; 2024 Jun; 25(1):92. PubMed ID: 38834953
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension.
Yiangou A; Mitchell JL; Vijay V; Grech O; Bilton E; Lavery GG; Fisher C; Edwards J; Mollan SP; Sinclair AJ
J Headache Pain; 2020 Sep; 21(1):116. PubMed ID: 32988380
[TBL] [Abstract][Full Text] [Related]
4. Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain?
De Simone R; Sansone M; Bonavita V
Neurol Sci; 2020 Dec; 41(Suppl 2):417-421. PubMed ID: 32852682
[TBL] [Abstract][Full Text] [Related]
5. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: A narrative review.
Mollan SP; Grech O; Sinclair AJ
Headache; 2021 Jun; 61(6):808-816. PubMed ID: 34106464
[TBL] [Abstract][Full Text] [Related]
6. Overlap and Differences in Migraine and Idiopathic Intracranial Hypertension.
Sengupta S; Vidwan J
Curr Pain Headache Rep; 2023 Nov; 27(11):653-662. PubMed ID: 37656318
[TBL] [Abstract][Full Text] [Related]
7. Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.
Yiangou A; Mitchell JL; Fisher C; Edwards J; Vijay V; Alimajstorovic Z; Grech O; Lavery GG; Mollan SP; Sinclair AJ
Headache; 2021 Jan; 61(1):157-169. PubMed ID: 33316102
[TBL] [Abstract][Full Text] [Related]
8. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
9. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
10. Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
Adderley NJ; Subramanian A; Perrins M; Nirantharakumar K; Mollan SP; Sinclair AJ
Neurology; 2022 Oct; 99(18):e1968-e1978. PubMed ID: 35985824
[TBL] [Abstract][Full Text] [Related]
11. The analysis of allodynia in patients with idiopathic intracranial hypertension.
Ekizoglu E; Baykan B; Orhan EK; Ertas M
Cephalalgia; 2012 Oct; 32(14):1049-58. PubMed ID: 22875880
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of papilledema in patients with migraine: a crucial cooccurrence of migraine and idiopathic intracranial hypertension.
Onder H; Ulusoy EK; Aslanyavrusu M; Akturk T; Arslan G; Akkurt I; Erkan E
Neurol Sci; 2020 Sep; 41(9):2613-2620. PubMed ID: 32458251
[TBL] [Abstract][Full Text] [Related]
13. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension.
Mollan SP; Wakerley BR; Alimajstorovic Z; Mitchell J; Ottridge R; Yiangou A; Thaller M; Gupta A; Grech O; Lavery G; Brock K; Sinclair AJ
J Headache Pain; 2021 Oct; 22(1):118. PubMed ID: 34620087
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
15. Developments in targeting calcitonin gene-related peptide.
Alabbad S; Figueredo N; Yuan H; Silberstein S
Expert Rev Neurother; 2024 May; 24(5):477-485. PubMed ID: 38557226
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Schifter S; Jansen-Olesen I; Olesen J
Neurology; 2000 Nov; 55(9):1335-40. PubMed ID: 11087777
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
Greco R; De Icco R; Demartini C; Zanaboni AM; Tumelero E; Sances G; Allena M; Tassorelli C
J Headache Pain; 2020 Oct; 21(1):122. PubMed ID: 33066724
[TBL] [Abstract][Full Text] [Related]
19. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
20. Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension.
Westgate CSJ; Israelsen IME; Jensen RH; Eftekhari S
J Headache Pain; 2021 Oct; 22(1):123. PubMed ID: 34629054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
